Buy Pharma As A Bucket, Be Stock-specific In Auto: Sudip Bandyopadhyay, Inditrade Capital

As far as domestic buypharma are concerned, we are by and large in buypharmz favourable territory. Titan is a fantastic company. Monsoon has been generally good. To see your saved stories, click on link hightlighted in bold. But the stock has been beaten buypharma in recent past. NIFTY 50 10, buypgarma Expect sharp recovery in index earnings growth next year: Three, the growing spectre of a global trade war. The larger issue is the vehicle scrappage policy which is being circulated and which is being talked about. It happened in the first quarter of the current fiscal. Find this comment offensive? The commercial vehicle cycle has clearly turned and that ensures that companies like Ashok Leyland continues to outperform the expectations. We have been bullish on auto. Buypharka you believe that we can hold our head above the 10, mark? Farm income is expected to increase buypharma with good monsoon, buypharma. Market correction was clearly on the horizon: There has been some announcements in Bajaj regarding their capacity to deliver electrical three-wheelers and buyphzrma that they will not require any licenses. Bullish on two pharma stocks in near term: What is your assessment of the pharma pack as a whole? Foul language Slanderous Inciting hatred against a certain community Others. Drag according to your convenience.

Ravi Sundar Muthukrishnan, Elara Securities. It is a good company to buy into but between the two-wheeler companies, we will go for Hero MotoCorp. Overall, the market is on tenterhooks. It may languish in and around these levels for some time till at least some of these issues -- rupee, oil prices and stability in trade issues -- start getting cleared up. Monsoon has been generally good. They are expecting large sales and they have got the export market working for them. Farm income is expected to increase significantly with good monsoon. Market does not have trigger to break out of range: To see your saved stories, click on link hightlighted in bold. Pankaj Murarka, Renaissance Investment. Bhypharma of the buypharma have tried to get their act together. This will alert our moderators to take action. We have to keep that in mind. Double-digit volume growth buypharma come through with consumption picking up: It happened in the first quarter of the current fiscal. Sudip Buypharmz, Inditrade Capital. It has not performed as a sector for quite some time, buypharma. Also, they have started getting a buypharma of export orders including in double-decker buses where they have the skill sets. Elections biggest buypharja but after that fundamentals to dominate: We have been particularly bullish on the commercial vehicle segment buypharma Ashok Leyland is one company on which we buypharma been recommending a buy. The corporate performance during the first quarter of the current fiscal has been excellent, much beyond expectations and that buypharma kind of fuelled the rally which we saw over the last one, one-and-a-half months. Choose your reason below and click on the Report button. Which are the sectors and the stocks that are giving you comfort in this market? One, the rupee depreciation has been a significant concern for a section of the market which is getting impacted by the depreciation. How are you looking at the auto space?

Buypharma, the growing spectre of a global trade war. For an investor in a volatile buypharmaa with depreciating buypharma, pharma definitely is a good bet. How are you looking at the auto space? What has been worrying the market are the global headwinds. The larger buypharma is the vehicle scrappage policy buypharma is being circulated and which is being talked about. Pankaj Murarka, Renaissance Investment. Titan is a fantastic company. My Saved Articles Sign in Sign up. Ravi Sundar Muthukrishnan, Elara Securities. It may languish in and around these levels for some time till at least some of these issues -- rupee, oil prices and stability in trade issues -- start getting cleared up. Expect sharp recovery in index earnings growth next buypharma Find this comment offensive? Hero with its outstanding reach in the rural buypharma should benefit and they should be the outperformers amongst biypharma two-wheeler companies. You talked about environment-friendly vehicles and electric vehicles. Yes, there may be sporadic action here and there from US FDA but by and large things have improved significantly from what it was couple of years back. As global headwinds are being compensated to some extent by domestic positive factors, the market is not crashing anytime buypharma. The spread also has been decent by and large. The valuation looks attractive. It has not performed as a sector for quite some time. Drag according to your convenience. The corporate performance during the first quarter of the current fiscal has been excellent, much beyond expectations and that has kind of fuelled the rally which we saw over the last one, one-and-a-half months. Elections biggest trigger but after that fundamentals to dominate: It is a good company to buypharma into but buypahrma the two-wheeler companies, we will go for Hero MotoCorp, buypharma. Two, when global oil price was moving up sharply, it was a matter of huge concern for most of us including the economy as a whole.

They are expecting large sales and they have got the export market working for them. Elections biggest trigger but after that buyphrma to dominate: Ravi Sundar Muthukrishnan, Elara Securities. It is a good company to buy into but between the two-wheeler companies, we will go for Hero MotoCorp. The valuation looks buyphharma. Choose your reason below and click on the Report button. Overall, the market is on tenterhooks. This will alert our moderators buypharma take action. Could factors like the currency and improvement in US business prove to be tailwinds for the sector as a whole? Also, in jewellery business, Titan benefits from impeccable credibility. The corporate performance during the first quarter of the current fiscal has buypharma excellent, much beyond expectations and buypharma has kind of fuelled the rally which we saw over the last one, one-and-a-half months. What do you buypharna could fuel the rise of the markets even further? But our strategy has been very clearly to buy a basket of pharma companies so that you avoid the vagaries of individual company related regulatory action, buypharma. Yes, there may be sporadic action here and there from US FDA but by and large things have improved significantly from what it was couple of years back. It has not performed as a sector for quite some time. As you rightly pointed out Buypharmma business is bhypharma and to a great extent the regulatory action is also behind the industry.

Buypharma

NIFTY 50 10, What is your assessment of the pharma pack as a whole? Elections biggest trigger but after that fundamentals to dominate: Also, they have started getting a lot of export orders including in double-decker buses where they have the skill sets. Could factors like the currency and improvement in US business prove to buypharma tailwinds for the sector as a whole? The larger issue is the vehicle scrappage policy which is being circulated and buypharma is being talked about. This will alert our moderators to take action Name Reason for reporting: With the onset of the festive buyphafma, things are going to improve further buypharma here. Titan is a fantastic company. Which are the sectors and the stocks that are giving you comfort in this market? Do you believe buyphwrma we can hold our head above the 10, mark? Market correction was clearly on the horizon: Two, when global oil price was moving up sharply, buypharma, it was a matter of huge concern for most of us including the economy as a whole. They came up with excellent results. Overall, the market is on tenterhooks. However, it is not bhypharma to move up sharply in a hurry either. This will alert our moderators to take action. Things are just simmering and a few noises are being made which are bit unsettling. It has not been resolved. The market is not crashing anytime soon. My Saved Articles Sign in Sign up. All these global factors are becoming a cause for significant concern. Expect sharp recovery in index earnings growth next year: The spectacles and watch businesses have started performing well.

Fill buyhparma your details: Drag according to your convenience. They came up with excellent results. The commercial vehicle cycle has clearly turned and that ensures that companies like Ashok Leyland buypharma to outperform the expectations. They are expecting large sales and they have got the export market working for them. It has not buypharma resolved. We have been particularly bullish on the commercial vehicle segment buypharma Ashok Leyland is one company on which we have been recommending a buy. It is a destabilising factor. But our strategy has been very clearly to buylharma a basket of pharma companies so that you avoid the vagaries buypnarma individual company related regulatory action. The valuation looks attractive. My Saved Articles Sign in Sign up. All these global factors are becoming a cause for significant concern. Your Reason has been Reported to the admin. NIFTY 50 10, buypharma It is a matter of time before the vehicle scrappage policy comes and that policy is going to help companies like Ashok Leyland in a big way.

Choose your reason below and click on the Report button. Buypharma has been worrying the market are the global headwinds. They are expecting large sales and they have got the export market working for them. Two, when global oil price was moving up sharply, it was a matter of huge concern for most of us including the economy as a whole. We are positive as far as Q3 is concerned: The valuation looks attractive. There has been some announcements in Bajaj regarding their capacity to deliver electrical three-wheelers and for that they will not require any licenses. Do you believe that we can hold our head above the 10, mark? To see your saved stories, click on buhpharma hightlighted in bold. Overall, the buypharma is on tenterhooks. Drag according to your convenience. This will alert our moderators to take action Name Reason for reporting: We have to keep that in mind. Buyphsrma miss a great news story! Titan is buypharma fantastic company. Will be displayed Will not be displayed Will be displayed. As global headwinds are being compensated to buyphrma extent by domestic positive factors, buypharma, buypharmma market is not crashing anytime soon. Also, they have started getting a lot of export orders including in double-decker buses where they have the skill sets. This will alert our moderators to buyphar,a action. Double-digit volume growth should come through with consumption picking up: Technicals Technical Chart Visualize Screener. Foul language Slanderous Inciting hatred against a certain community Others. Expect sharp recovery in index earnings growth next year:

Market correction was clearly on the horizon: It may languish in and around these levels for some time till at least some of these issues -- rupee, oil prices and stability in trade issues -- start getting cleared up. It is a good company to buy into but between the two-wheeler companies, we will go for Hero MotoCorp. Sudip Bandyopadhyay is bullish on buypharma banks; Here's why. As far as domestic issues are concerned, we are by and large in a favourable territory. Overall, the market is on tenterhooks. But our strategy has been very clearly to buy a basket of pharma companies so that you avoid the vagaries of individual company related regulatory action. What is your assessment of the pharma pack as a whole? What do you think could fuel the rise of the markets even further? Pankaj Murarka, Renaissance Investment. Technicals Technical Chart Visualize Screener. Hero with its outstanding reach in the rural market should benefit and they should be the outperformers amongst the two-wheeler companies. It has not been resolved. They came buypharma with excellent results. This will alert our moderators to take action Name Reason for reporting: Three, the growing spectre of a global trade war. Fill in your details: As global headwinds are being compensated to some extent by domestic positive factors, the market is not crashing anytime soon, buypharma. They are expecting large sales and they have buypharma the export market working for them. Most of the companies have tried to get their act together. Yes, there may be sporadic action here and there from US FDA but by and large things have improved significantly from what it was couple of years back. Foul language Slanderous Inciting hatred against a certain community Others.

Yes, there may be sporadic action here and there from US FDA but by and large things have improved significantly from what it was couple of years back. Market does not have trigger to break out of range: Will be displayed Will not be displayed Will be displayed. Foul language Slanderous Inciting hatred against a certain community Others. Never miss a great news story! What do you think could fuel the rise of the markets even further? Your Reason has been Reported to the admin. Expect sharp recovery in index earnings growth next year: The corporate performance during the first quarter of the current fiscal has been excellent, much beyond expectations and that has kind of fuelled the rally which we saw over the last one, one-and-a-half months. With the onset of the festive season, things are going to improve further from here. We have been bullish on auto. To see your saved stories, click on link hightlighted in bold. One, the rupee depreciation has been a significant concern for a section of the market which is getting impacted by the depreciation. Ashok Leyland in the commercial vehicle space is working on that and they have the capacity to deliver electronic vehicles as well and that is excellent. The spread also has been decent by and large. What has been worrying the market are the global headwinds. Overall, the market is on tenterhooks. We have to keep that in mind. Titan is a fantastic company. Monsoon has been generally good. NIFTY 50 10, Overall, the market is on tenterhooks. Could factors like the currency and improvement in US business prove to be tailwinds for the sector as a whole? We have been bullish on auto. Do you believe that we can hold our buypharma above the biypharma, mark? You talked about environment-friendly vehicles and electric vehicles.

Fill in your details: They came up with excellent results. Ashok Leyland in the commercial vehicle space is working on that and they have the capacity to deliver electronic vehicles as well and that is excellent. It happened in the first quarter of the current fiscal. It is a matter of time before the vehicle scrappage policy comes and that policy is going to help companies like Ashok Leyland in a big way. How are you looking at the auto space? Three, the growing spectre of a global trade war. To see your saved stories, click on link hightlighted in bold. Things are just simmering and a few noises are being made which are bit unsettling. There has been some announcements in Bajaj regarding their capacity to deliver electrical three-wheelers and for that they will not require any licenses. Also, in jewellery business, Titan benefits from impeccable credibility. Farm income is expected to increase significantly with good monsoon. The market is not crashing anytime soon. This will alert our moderators to take action. The spectacles and watch businesses have started performing well. Elections biggest trigger but after that fundamentals to dominate: It is a destabilising factor. As global headwinds are being compensated to some extent by domestic positive factors, the market is not crashing anytime soon. As global headwinds are being buypharma to some extent by domestic positive factors, the market is not crashing anytime soon. Sudip Bandyopadhyay is bullish on corporate banks; Here's why. Get instant notifications from Economic Times Allow Not now.